Biological scaffold for repairing anterior cruciate ligament as well as preparation method and application of biological scaffold

By adjusting collagen content and enriching platelet plasma by using hydroxyproline assay, combining stem cells to form collagen-PRP hydrogel biological scaffolds, the problem of structural relaxation and healing difficulties in anterior cruciate ligament repair is solved, and more Effectively heal and reduce the risk of osteoarthritis.

CN119015505APending Publication Date: 2024-11-26BEIJING CHUNLIZHENGDA MEDICAL INSTR
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411101611.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art has problems such as structural relaxation, osteoarthritis, autologous transplant donor area complications, allograft rejection and artificial ligament material aging in the repair of the anterior cruciate ligament, and the difficulty in forming fibrin-platelet clots leads to healing difficulties.

Method used

The collagen content was adjusted by hydroxyproline assay, combined with platelet-rich plasma (PRP) and stem cells, and collagen-PRP hydrogel was used as a bridge, mounted on polypropylene sutures to form a biological scaffold to bridge the tear's anterior crossover. Ligament stumps support cell migration and proliferation and promote healing.

Benefits of technology

Promotes the body's own healing, reduces the risk of osteoarthritis, eliminates the incidence of donor sites, restores normal joint mechanics, is suitable for a variety of tear types, the scaffold is replaced by natural cells and collagen within eight weeks, and new tissues are remodeled and strengthened .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015505A_ABST
    Figure CN119015505A_ABST
Patent Text Reader

Abstract

The invention relates to an anterior cruciate ligament repair biological scaffold and a preparation method and application thereof, and relates to the technical field of biological scaffolds, the anterior cruciate ligament repair biological scaffold provided by the invention is a decellularized bovine-derived I-type collagen implant, and can be absorbed within 8 weeks after implantation. The biological scaffold which carries the platelet-enriched plasma and can resist synovial fluid degradation is combined with the technologies of the biological scaffold, the platelet-enriched plasma, stem cells and the like, contains other extracellular matrix molecules, does not have a chemical cross-linking agent, takes a polypropylene suture line as a guide, takes collagen-PRP hydrogel as a bridge, and is in bridge connection with a torn anterior cruciate ligament stump. Diseases and related technical difficulties in anterior cruciate ligament reconstruction can be effectively solved, and the defects in the prior art are overcome.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biological scaffolds, and in particular to an anterior cruciate ligament repair biological scaffold and a preparation method and application thereof. Background Art

[0002] The current treatment for repairing anterior cruciate ligament rupture in humans is to remove the ruptured fan-shaped ligament and replace it with a point-to-point tendon graft (ACL reconstruction), which needs to be obtained from other parts of the patient's leg or from a donor. Artificial synthetic ligament substitutes have also been developed. These include grafts made of carbon fiber, GoreTex and other synthetic materials. For grafts made of natural or synthetic materials, the fibers of the graft are oriented so that they are parallel to the tension lines in the ligament, that is, the direction of the long axis of the ligament. These structures allow the structure to support tensile loads during healing. Although this approach can initially restore overall stability in most patients, many patients have abnormal structural laxity after surgery, and more than 70% of ACL reconstruction patients develop osteoarthritis after injury; at the same time, important proprioceptive nerve fibers need to be removed, which is important for knee stability.

[0003] Among ACL reconstruction grafts, autologous tissue has been widely recognized for its relatively reliable long-term efficacy. The most common locations for collecting tissue grafts are from the patellar tendon in the front of the knee or the hamstring tendon in the back of the thigh, but there is a risk of donor site complications, including pain, weakness, and altered joint mechanics, which in turn affect knee function. Allogeneic materials do not require the sacrifice of autologous tissue, but there are many problems such as limited tissue sources, donor quality, ethical issues, potential rejection reactions, risk of disease transmission, and high failure rates. There are still some shortcomings in artificial ligament reconstruction of ACL, such as the lack of viscoelasticity of the ligament itself and the possible aging of polyester fibers. The reconstruction cannot withstand the physiological forces applied over time.

[0004] Existing treatments can only reconstruct the ligament but not repair it. The main obstacle in the anterior cruciate ligament repair process is the difficulty in forming a fibrin-platelet clot, which may be caused by the harsh mechanical environment caused by the loss of knee joint stability after the anterior cruciate ligament is torn. In addition, the synovial fluid in the joint can inhibit the action of anterior cruciate ligament fibroblasts, and the fibrinolytic protease in the synovial fluid prematurely breaks down the fibrin clot. Therefore, developing a ligament repair technique that can solve the problem of healing the internal environment of the synovial fluid around the knee joint, retain the native ACL tissue, and does not require the acquisition of transplanted tissue - "ligament repair bioscaffold" is one of the current important research topics in this field. Summary of the invention

[0005] In order to solve the above problems, the present invention provides an anterior cruciate ligament repair biological scaffold and a preparation method and application thereof.

[0006] In a first aspect, the present invention provides a method for preparing a biological scaffold for repairing anterior cruciate ligament, the preparation method comprising the following steps:

[0007] (1) The collagen content in the slurry was adjusted using the hydroxyproline assay; the collagen slurry was mixed with HEPES, 10× Ham's F10, mixed penicillin / streptomycin / amphotericin B and sterile water before being combined with the platelet component of the hydrogel, and then the collagen slurry was neutralized with sodium bicarbonate;

[0008] (2) Whole blood was drawn from autologous or allogeneic veins immediately before surgery and placed in tubes containing sodium citrate. The blood was centrifuged at 100 g for 14 minutes to separate the platelet-rich plasma (PRP) fraction;

[0009] (3) Add PRR to the collagen slurry and keep the mixture on ice until use.

[0010] Furthermore, in step (1), the collagen content in the slurry is adjusted to about 10 mg / mL, and 0.01 M HCl is added as needed.

[0011] Furthermore, the collagen slurry in step (1) is mixed with 30% 0.1M HEPES, 20% 10×Ham's F10, 30% mixed penicillin / streptomycin / amphotericin B and 30% sterile water.

[0012] Furthermore, in the step (1), the mass fraction of the sodium bicarbonate solution is 7.5%, which is neutralized to 7.5.

[0013] Furthermore, in step (3), after PRP is added to the collagen slurry, the ratio of plasma to collagen is maintained at 1:2.

[0014] In a second aspect, the present invention provides an anterior cruciate ligament repair biological scaffold, wherein the anterior cruciate ligament repair biological scaffold is prepared by the preparation method of the anterior cruciate ligament repair biological scaffold described in any one of the first aspects.

[0015] Furthermore, the shape of the anterior cruciate ligament repair biological scaffold includes a cylinder.

[0016] Furthermore, the property parameters of the cylinder include: a bottom diameter of 20 to 25 mm and a height of 40 to 50 mm.

[0017] In a third aspect, the present invention provides use of the anterior cruciate ligament repair biological scaffold described in any one of the first aspect and the second aspect in preparing an anterior cruciate ligament repair system and / or in anterior cruciate ligament repair.

[0018] In a fourth aspect, the present invention provides an anterior cruciate ligament repair system, the anterior cruciate ligament repair system comprising: a drilling device, a first fixation device located on the femur, a second fixation device located on the tibia, a first suture, a second suture, a first bracket, and a second bracket;

[0019] The first stent and the second stent are both the anterior cruciate ligament repair biological stents according to any one of the first aspect and the second aspect;

[0020] The drilling device is used to drill holes in the femur and tibia;

[0021] The first fixing device located on the femur is used to fix the first suture end and the second suture end on the femur;

[0022] The second fixation device located on the tibia is used to fix the first suture end and the second suture end on the tibia;

[0023] The first suture is used to deliver the first stent into the intercondylar notch;

[0024] The second suture is used to deliver the second stent into the intercondylar notch.

[0025] The above technical solution provided by the embodiment of the present invention has at least the following advantages compared with the prior art:

[0026] The embodiments of the present invention provide a biological scaffold for repairing anterior cruciate ligament, and a preparation method and application thereof. The present invention has developed a biological scaffold that can carry PRP and resist synovial degradation. It combines biological scaffolds, platelet-rich plasma (PRP), stem cells and other technologies, uses polypropylene sutures as a guide, and uses collagen-PRP hydrogel as a bridge to bridge the torn anterior cruciate ligament stump, which can overcome the symptoms and related technical difficulties that occur during anterior cruciate ligament reconstruction: 1. Abnormal structural relaxation and osteoarthritis in patients after surgery. 2. Removal of important proprioceptive nerve fibers affects the stability of the knee joint. 3. Autologous transplantation has the risk of donor site complications, allogeneic transplantation has rejection reactions, the risk of disease transmission, and artificial ligaments have material aging and other problems. 4. Torn anterior cruciate ligaments cannot heal and other problems. It makes up for the shortcomings of the existing technology. Specifically, the advantages are as follows: 1. The ACL repair scaffold promotes the body's own healing response by supporting cell migration and proliferation; 2. Within eight weeks, the ACL repair scaffold is reabsorbed and replaced by natural cells, collagen and blood vessels, and the new tissue continues to reshape and strengthen over time; 3. Eliminate donor site morbidity; 4. Have the potential for more normal joint mechanics; 5. Reduce the possibility of post-traumatic osteoarthritis; 6. No deceased donor tissue is required, and there are no special requirements for the storage / handling of the implant; 7. Suitable for a variety of tear types (type 1 to type 4). BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.

[0028] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0029] Figure 1 A schematic diagram of an anterior cruciate ligament repair biological scaffold provided in an embodiment of the present invention.

[0030] Figure 2 Schematic diagram of the operation of the anterior cruciate ligament repair system provided by the embodiment of the present invention in the anterior cruciate ligament repair Figure 1 .

[0031] Figure 3 Schematic diagram of the operation of the anterior cruciate ligament repair system provided by the embodiment of the present invention in the anterior cruciate ligament repair Figure 2 .

[0032] Figure 4 Schematic diagram of the operation of the anterior cruciate ligament repair system provided by the embodiment of the present invention in the anterior cruciate ligament repair Figure 3 .

[0033] Figure 5 Schematic diagram of the operation of the anterior cruciate ligament repair system provided by the embodiment of the present invention in the anterior cruciate ligament repair Figure 4 .

[0034] Figure 1 Middle: 12 represents sutures, and 18 represents biological scaffolds.

[0035] Figure 2 and Figure 5 Middle: 4 is the femur, 6 is the tibia, 12 is the suture, 14 is the button, 16 is the drill hole, 18 is the first bracket, and 20 is the second bracket. DETAILED DESCRIPTION

[0036] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.

[0038] In a first aspect, the present invention provides a method for preparing a biological scaffold for repairing anterior cruciate ligament, the preparation method comprising the following steps:

[0039] (1) The collagen content in the slurry was adjusted using the hydroxyproline assay. Prior to combining with the platelet component of the hydrogel, the collagen slurry was mixed with HEPES, 10× Ham's F10, mixed penicillin / streptomycin / amphotericin B and sterile water, and then neutralized with sodium bicarbonate.

[0040] (2) Immediately before surgery, whole blood was drawn from an autologous or allogeneic vein and placed in a tube containing sodium citrate. The blood was centrifuged at 100 g for 14 minutes to separate the platelet-rich plasma (PRP) fraction.

[0041] (3) Add PRR to the collagen slurry, place the mixture in a mold, and store on ice until use.

[0042] The embodiment of the present invention provides a biological scaffold for repairing anterior cruciate ligament. The present invention has developed a biological scaffold that can carry PRP and resist synovial degradation. It combines biological scaffolds, platelet-rich plasma (PRP), stem cells and other technologies, uses polypropylene sutures as a guide, and uses collagen-PRP hydrogel as a bridge to bridge the torn anterior cruciate ligament stump, which can overcome the symptoms and related technical difficulties that occur during anterior cruciate ligament reconstruction: 1. Abnormal structural relaxation and osteoarthritis in patients after surgery. 2. Removal of important proprioceptive nerve fibers affects the stability of the knee joint. 3. Autologous transplantation has the risk of donor site complications, allogeneic transplantation has rejection reactions, the risk of disease transmission, and artificial ligaments have material aging and other problems. 4. The torn anterior cruciate ligament cannot heal and other problems. It makes up for the shortcomings of the existing technology. Specifically, the advantages are as follows: 1. The ACL repair scaffold promotes the body's own healing response by supporting cell migration and proliferation; 2. Within eight weeks, the ACL repair scaffold is reabsorbed and replaced by natural cells, collagen and blood vessels, and the new tissue continues to reshape and strengthen over time; 3. Eliminate donor site morbidity; 4. Have the potential for more normal joint mechanics; 5. Reduce the possibility of post-traumatic osteoarthritis; 6. No deceased donor tissue is required, and there are no special requirements for the storage / handling of the implant; 7. Suitable for a variety of tear types (type 1 to type 4).

[0043] In some specific embodiments, in step (1), the collagen content in the slurry is adjusted to about 10 mg / mL, and 0.01 M HCl is added as needed.

[0044] In some specific embodiments, the collagen slurry in step (1) is mixed with 30% 0.1M HEPES, 20% 10× Ham's F10, 30% mixed penicillin / streptomycin / amphotericin B and 30% sterile water.

[0045] In some specific embodiments, the mass fraction of the sodium bicarbonate solution in step (1) is 7.5%, which is neutralized to 7.5.

[0046] In some specific embodiments, after adding PRP to the collagen slurry in step (3), the ratio of plasma to collagen is maintained at 2:1.

[0047] In a second aspect, the present invention provides an anterior cruciate ligament repair biological scaffold, wherein the anterior cruciate ligament repair biological scaffold is prepared by the preparation method of the anterior cruciate ligament repair biological scaffold described in any one of the first aspects.

[0048] In some specific embodiments, Figure 1 As shown, the shape of the anterior cruciate ligament repair biological scaffold includes a cylinder.

[0049] In some specific embodiments, the property parameters of the cylinder include: a bottom diameter of 20 to 25 mm and a height of 40 to 50 mm.

[0050] In a third aspect, the present invention provides use of the anterior cruciate ligament repair biological scaffold described in any one of the first aspect and the second aspect in preparing an anterior cruciate ligament repair system and / or in anterior cruciate ligament repair.

[0051] In a fourth aspect, the present invention provides an anterior cruciate ligament repair system, the anterior cruciate ligament repair system comprising: a drilling device, a first fixation device located on the femur, a second fixation device located on the tibia, a first suture, a second suture, a first bracket, and a second bracket;

[0052] The first stent and the second stent are both the anterior cruciate ligament repair biological stents according to any one of the first aspect and the second aspect;

[0053] The drilling device is used to drill holes in the femur and tibia;

[0054] The first fixing device located on the femur is used to fix the first suture end and the second suture end on the femur;

[0055] The second fixation device located on the tibia is used to fix the first suture end and the second suture end on the tibia;

[0056] The first suture is used to deliver the first stent into the intercondylar notch;

[0057] The second suture is used to deliver the second stent into the intercondylar notch.

[0058] In some specific embodiments, the anterior cruciate ligament repair system provided by the embodiments of the present invention is applied to anterior cruciate ligament repair, such as Figure 2-Figure 5 First, holes 16 are drilled in the femur 4 and tibia 6, being careful not to damage the anterior cruciate ligament insertion site on each bone or the ligament itself. Sutures (i.e., first and second sutures) 12 are then placed on buttons (i.e., first fixation devices, such as titanium plates or anchors) 14, as shown. Figure 2 As shown, the button is passed upward through the femoral tunnel and turned over to fix the two suture ends to the femur. The first bracket 18 is passed upward along one end of the suture into the intercondylar notch. Then the second bracket 20 is fed into the incision along the second suture. The suture ends are then passed through the tibial tunnel, and the suture ends are tied to the button or another fixing device (i.e., the second fixing device) is used to fix the suture ends to the tibia.

[0059] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are usually measured according to national standards. If there is no corresponding national standard, then the conditions recommended by the manufacturer are followed.

[0060] Example 1

[0061] This example provides an anterior cruciate ligament repair biological scaffold and a preparation method thereof, comprising the following steps:

[0062] Step (1): The collagen content in the slurry was adjusted to about 10 mg / mL using the hydroxyproline assay, and 0.01 M HCl was added as needed. Before combining with the platelet component of the hydrogel, the collagen slurry was mixed with 30% 0.1 M HEPES, 20% 10× Ham's F10, 30% mixed penicillin / streptomycin / amphotericin B and 30% sterile water, and then the collagen slurry was neutralized to 7.5 with 7.5% sodium bicarbonate;

[0063] Step (2): Immediately before surgery, whole blood was drawn from an autologous or allogeneic vein and placed in a tube containing sodium citrate. The blood was centrifuged at 100 g for 14 minutes to separate the platelet-rich plasma (PRP) fraction;

[0064] Step (3): After adding PRP to the collagen slurry, the ratio of plasma to collagen was maintained at 2:3;

[0065] Step (4): Place the mixture in a mold and store it on ice until use to obtain the anterior cruciate ligament repair biological scaffold.

[0066] The anterior cruciate ligament repair biological scaffold provided in this example is prepared by dissolving bovine connective tissue to prepare extracellular matrix protein slurry, adjusting the collagen concentration to a minimum of 10 mg / ml and freeze-drying. Figure 1 As shown, the bio-enhanced ACL repair scaffold is a porous cylinder with a diameter of 22 mm and a length of 40 mm. The scaffold is stored at -20°C until the day of surgery. At the time of surgery, the scaffold is implanted either as a complete cylinder or as multiple cylinders. When implanted into the joint, the bioactive scaffold, platelets are added as a repair material.

[0067] Example 2

[0068] This example provides an anterior cruciate ligament repair system, the anterior cruciate ligament repair system comprising: a drilling device, a first fixation device located on the femur, a second fixation device located on the tibia, a first suture, a second suture, a first bracket, and a second bracket;

[0069] The first stent and the second stent are both the anterior cruciate ligament repair biological stents provided in Example 1;

[0070] The drilling device is used to drill holes in the femur and tibia;

[0071] The first fixing device located on the femur is used to fix the first suture end and the second suture end on the femur;

[0072] The second fixation device located on the tibia is used to fix the first suture end and the second suture end on the tibia;

[0073] The first suture is used to deliver the first stent into the intercondylar notch;

[0074] The second suture is used to deliver the second stent into the intercondylar notch.

[0075] When used in anterior cruciate ligament repair, Figure 2-Figure 5 First, holes 16 are drilled in the femur 4 and tibia 6, being careful not to damage the anterior cruciate ligament insertion site on each bone or the ligament itself. Sutures (i.e., first and second sutures) 12 are then placed on the button (i.e., first fixation device) 14, as shown. Figure 2 As shown, the button is passed upward through the femoral tunnel and turned over to fix the two suture ends to the femur. The first bracket 18 is passed upward along one end of the suture into the intercondylar notch. Then the second bracket 20 is fed into the incision along the second suture. The suture ends are then passed through the tibial tunnel, and the suture ends are tied to the button or another fixing device (i.e., the second fixing device) is used to fix the suture ends to the tibia.

[0076] Biomechanical Testing: AP knee laxity was measured at 30°, 60°, and 90° of knee flexion by applying a fully reversed sinusoidal anteroposterior directed shear load of ±40N at 0.0833(1 / 12)Hz at each knee angle. A standardized failure testing protocol was used to determine the structural properties of the ligaments and grafts. Prior to initiating the tensile test, the femur was lowered to a load of +5N compression on the articular surface. A 20mm / min ramp was initiated and load-displacement data were recorded at 100Hz. Yield load, linear stiffness were determined from the MTS load-displacement data.

[0077] The average maximum loads of the three groups (complete, few segments, and multiple segments) were 155 N, 673 N, and 956 N, respectively, and the linear stiffnesses were 35 N, 142 N, and 185 N, respectively. It can be seen that the repair is more effective when the scaffold is divided into multiple parts rather than as a complete longitudinal structure that repairs the entire distance between the two ends of the bone or ligament.

[0078] Various embodiments of the present invention may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present invention; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values ​​within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.

[0079] The foregoing is merely a specific embodiment of the present invention, which enables those skilled in the art to understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features claimed herein.

Claims

1. A method for preparing a biological scaffold for repairing anterior cruciate ligament, characterized in that: The preparation method comprises the following steps: (1) The collagen content in the slurry was adjusted using the hydroxyproline assay; the collagen slurry was mixed with HEPES, 10× Ham's F10, mixed penicillin / streptomycin / amphotericin B and sterile water before being combined with the platelet component of the hydrogel, and then the collagen slurry was neutralized with sodium bicarbonate; (2) Whole blood was drawn from autologous or allogeneic veins immediately before surgery and placed in tubes containing sodium citrate; the blood was centrifuged at 100 g for 14 minutes to separate the PRP fraction; (3) Add PRR to the collagen slurry and keep the mixture on ice until use.

2. The method for preparing the anterior cruciate ligament repair biological scaffold according to claim 1, characterized in that: In the step (1), the collagen content in the slurry is adjusted to about 10 mg / mL, and 0.01 M HCl is added as needed.

3. The method for preparing the anterior cruciate ligament repair biological scaffold according to claim 1, characterized in that: In step (1), the collagen slurry is mixed with 30% 0.1M HEPES, 20% 10× Ham's F10, 30% mixed penicillin / streptomycin / amphotericin B and 30% sterile water.

4. The method for preparing the anterior cruciate ligament repair biological scaffold according to claim 1, characterized in that: The mass fraction of the sodium bicarbonate solution in step (1) is 7.5%, which is neutralized to 7.

5.

5. The method for preparing the anterior cruciate ligament repair biological scaffold according to claim 1, characterized in that: After centrifugation in step (2), the platelet concentration ranges from 495 to 567 K / mm 3 To 780~2300K / mm 3 .

6. The method for preparing anterior cruciate ligament repair biological scaffold according to claim 1, characterized in that: In the step (3), after PRP is added to the collagen slurry, the ratio of plasma to collagen is maintained at 1:

1.

7. A biological scaffold for repairing anterior cruciate ligament, characterized in that: The anterior cruciate ligament repair biological scaffold is prepared by the preparation method of the anterior cruciate ligament repair biological scaffold according to any one of claims 1 to 5.

8. The anterior cruciate ligament repair biological scaffold according to claim 6, characterized in that: The shape of the anterior cruciate ligament repair biological scaffold includes a cylinder; the property parameters of the cylinder include: a bottom diameter of 20 to 25 mm and a height of 40 to 50 mm.

9. Use of the anterior cruciate ligament repair biological scaffold according to any one of claims 1 to 8 in preparing an anterior cruciate ligament repair system and / or in anterior cruciate ligament repair.

10. An anterior cruciate ligament repair system, characterized in that: The anterior cruciate ligament repair system includes: a drilling device, a first fixation device located on the femur, a second fixation device located on the tibia, a first suture, a second suture, a first bracket and a second bracket; The first stent and the second stent are both the anterior cruciate ligament repair biological stent according to any one of claims 1 to 8; The drilling device is used to drill holes in the femur and tibia; The first fixing device located on the femur is used to fix the first suture end and the second suture end on the femur; The second fixation device located on the tibia is used to fix the first suture end and the second suture end on the tibia; The first suture is used to deliver the first stent into the intercondylar notch; The second suture is used to deliver the second stent into the intercondylar notch.